The size of the Cell Culture Market in the Middle East & Africa is projected to reach USD 1.33 billion in 2022 and grow USD 2.14 Billion by 2027. It is estimated to be growing at a CAGR of 9.99% during the forecast period.
Cell culture is the maintenance and growth of cells of animals, plants, or microbes outside the body in specially designed environments under precise conditions of temperature, humidity, nutrition, and pH. In a much broader sense, when complete tissues or even organs are isolated and maintained in a laboratory, it is called tissue culture. Both have some similarities, but cell culture has more influence than tissue culture.
Cell cultures are divided into three categories, namely primary, secondary, and cell line cell culture. The techniques associated with cell culture have helped scientists to use cultures of cells for various experimental studies and biological assays of many types. The laboratory technique of maintaining cell lines developed during the mid-20th century. It involves growing a population of cells descended from a single cell and hence have the same genetic makeup.
The significant factors affecting the Middle-East & Africa Cell Culture market include the rise of infectious diseases in the region and the subsequent demand for drugs and antibodies. The 3D cell culture is another branch that has shown promise in the area. Smaller companies entering the market due to this is another factor that bolsters market growth in the region.
Despite the positives associated with it, the market is not thriving in the region mainly due to the high costs associated with the research as well as the equipment; being a not so economically rich region, the governments of most nations in the area are not willing to spend the massive amounts of money that are required for the industry to thrive in the region.
This research report on the MEA Cell Culture Market has been segmented and sub-segmented into the following categories:
By End User:
Geographically, Middle East & Africa is expected to grow at steady CAGR during the forecast period. Increasing prevalence to improve the healthcare units in the hospitals and clinics is a major factor for the market to grow high in this region. A growing number of patients with different chronic diseases and increasing communicable diseases are likely to flourish the demand of the Middle East and Africa cell culture market. According to the WHO, influenza A and B cases were 70,532 in the MEA region, and the number is estimated to increase by 2025. Growing demand to improve the healthcare infrastructure is escalating the growth rate of the market. The market in the UAE held the highest market shares in 2019 and is to continue the same flow in the coming years. Focus on the development of various innovative projects is greatly influencing the demand of the market. Rising investments in R&D activities by government organizations are leveling up the growth rate of the cell culture market in the UAE. Saudi Arabia is deemed to have growth opportunities in the near future. Growing prominence to develop vaccines or drugs in favor of the end-users is escalating the demand of the market in this country.
Key market participants dominating the MEA Cell Culture Market profiled in this report are Thermo Fisher Scientific, GE Healthcare, Merck KGaA, Sartorius AG, Eppendorf AG, Lonza AG, Corning, Becton, Dickinson and Company, Promocell GmbH, and Hi-Media Laboratories.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com